James Noble

Overview

James Noble received an average of $2M in total compensation, including $505K in salary, at Adaptimmune Therapeutics from 2015 to 2019.

Related executives

We found six more executives who work or worked at Adaptimmune Therapeutics.

Adrian Rawcliffe

Adaptimmune Therapeutics

Chief Executive Officer

Helen Tayton-Martin

Adaptimmune Therapeutics

Chief Business Officer

William Bertrand

Adaptimmune Therapeutics

Chief Operating Officer

Gavin Wood

Adaptimmune Therapeutics

Chief Financial Officer

John Lunger

Adaptimmune Therapeutics

Chief Operating Officer

Rafael Amado

Adaptimmune Therapeutics

President, Research & Development

News

You may also like